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BPTF Enhances Chemotherapy Dependent Cytotoxicity
There are approximately 170,000 cases of Triple-Negative Breast Cancer (TNBC) 
in the United States. TNBC treatment is inefficient due to infrequent response to 
immunotherapies, and because of its resistance to common cancer chemotherapies.
The nucleosome remodeling factor (NURF) is a chromatin remodeling complex 
composed of 3 core subunits with the BPTF being essential for function. BPTF is 
commonly over-expressed in cancers and has shown to be associated with 
increasing tumor growth and developing a malignant phenotype. These functions 
suggest that NURF may act as a suppressor for the anti-tumor immune response. 
Furthermore, in response to chemotherapies cancer cells often undergo the process 
of Autophagy. In this process, cells consume their cellular components to conserve 
energy and repair damage. Autophagy is regulated by many different proteins with 
one of them being ATG5. ATG5 is a protein that is involved in the extension of the 
isolation membrane into an autophagosome.
• Aim 1: Determine if BPTF-KD TNBCs are sensitive to chemotherapies. It is 
expected that cells with BPTF-KD will have sensitivity to some chemotherapies.
• Aim 2: To investigate the role of autophagy in the sensitization of BPTF-KD 
cells to chemotherapies. It is expected that BPTF-KD cells will have an 
enhanced sensitivity to Doxorubicin through the blockade of autophagy by ATG5 
KD. 4T1 TNBC cells with BPTF and ATG5-KD will be transplanted into mice and 
tumor weight will be measured to see the response of the cells to chemotherapy 
after autophagy inhibition in vivo. 
• Aim 3: Determine the possible molecular consequences of treating BPTF-KD 
cells with chemotherapies. Natural Killer (NK) cells will be depleted in mice to 
investigate role in sensitization to therapies. 
Ultimately this thesis’ goal is to develop strategies combining NURF 
targeted therapies with breast cancer chemotherapies to improve clinical 
outcomes.
• Short hairpin RNA was used for BPTF and ATG5-KD which was confirmed 
through Western Blot.
• Clonogenic survival assays were used to see the effects chemotherapies on the 
BPTF-KD cells as well to investigate the roll of autophagy in plated cells. 
• Acridine staining was used to test for enhanced levels of autophagy in BPTF-KD 
cells
• Clonogenic survival assays were used to measure toxicity of chemotherapies to 
BPTF-KD cells.
• Blockade of autophagy after ATG5-KD was measured by LC3B-I conversion to 
LC3B-II.  
• Syngeneic mouse models were used to determine sensitization to Doxorubicin 
with BPTF-KD as well as with ATG5-KD in vivo. 
• Mass spectrometry was used to measure eicosanoid abundance in culture media.
• Reverse ELISA was used to analyze PGE2 concentration in all the cell lines. 
• rt-PCR was used to analyze cytokine gene expression data. 
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Figure 2 shows sensitization to different types 
of chemotherapies in the WT, KD1 and KD2 
cell lines. The highest sensitization can be 
seen in Doxorubicin as it has the smallest 
number of viable cells in KD1 and KD2 cell 
lines. 
Figure 3 Acridine Orange 
staining shows enhanced 
autophagy in cells treated with 
chemotherapies in comparison to 
controls.
Figure 4 shows ATG5-KD. 
Cyclophilin B is shown as the loading 
control and BPTF-KD is also shown 
for KD1 and KD2 cell lines.
Figure 5 shows functional blockade 
of autophagy through LC3B-I 
conversion to LC3B-II. GAPDH is 
used as loading control.
Figure 6 clonogenic survival assays suggest 
that autophagy is cytoprotective in WT cells 
and nonprotective in BPTF-KD cells.
Figure 7 shows results from syngeneic mouse 
models. It shows sensitization to Doxorubicin 
in BPTF-KD cells, but no sensitization in 
BPTF-WT cells that were ATG5-KD.
Figure 8 shows that when 
we KD Natural Killer (NK) 
cells in mice they lose that 
initially seen sensitization to 
Doxorubicin. 
Figure 9 reductions in PGE2 (known 
NK cell inhibitor) seen in BPTF-KD 
cells treated with chemotherapy
Figure 10 shows a visible 
reduction in PGE2 when 
autophagy was blocked in the 
BPTF-KD cells. 
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• Aim 1 results: Sensitivity is enhanced to select chemotherapies when NURF is 
depleted with BPFT-KD. Results also show enhanced autophagy in BPTF-KD cells treated 
with Doxorubicin. Doxorubicin had the lowest amount of viable cells.
• Aim 2 results: ATG5 KD increased sensitization to Doxorubicin in BPTF-WT cells but 
not BPTF-KD cells. This suggests that the autophagy is cytoprotective in the WT cells 
and nonproductive in the BPTF KD cells. BPTF-KD cell lines (KD1 & KD2) showed 
sensitization to Doxorubicin in syngeneic mouse models. Mouse models also showed 
sensitization in ATG5-KD cell lines with BPTF-WT but not the cell lines with BPTF-KD.
• Aim 3 results show that when Natural Killer cells are depleted in mice, the initial 
sensitization is lost. This could be explained by cytokine or metabolite secretion to the 
tumors or by altered gene expression. The metabolomics screen showed reductions in 
PGE2 in the BPTF-KD cells treated with chemotherapies. This explains improvements in 
tumor growth seen in the mice since PGE2 is a known NK cell inhibitor. rt-PCR analysis of 
cytokine gene expression in the BPTF-KD and the ATG5-KD cells showed no significant 
expression in any of the cytokines within the cell lines. The PGST1 and PGST2 gene 
expression data suggests that COX 2 is regulated by autophagy and autophagy is important 
for PGE2 secretion  with or without Doxorubicin. 
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Figure1 shows BPTF-KD 
(KD1 and KD2) in the 4T1 
mouse TNBC cell line. It 
also shows no reductions in 
any of the other subunits. 
Cyclophilin B is used as 
loading control.
Figure 11
Figure 11 shows increase in 
COX 1 and COX 2  
expression in Doxorubicin 
treated cell lines. COX 2 
expression is higher in 
ATG5-KD cells.
